发明名称 LI-Key/Antigenic epitope hybrid peptide vaccines
摘要 Disclosed is an antigen presentation enhancing hybrid polypeptide which includes three elements. The first element is an N-terminal element consisting essentially of 4-16 residues of the mammalian li-Key peptide LRMKLPKPPKPVSKMR (SEQ ID NO: _) and non-N-terminal deletion modifications thereof that retain antigen presentation enhancing activity. The second element is a chemical structure covalently linking the N-terminal element described above to the MHC Class II-presented epitope described below. The chemical structure is a covalently joined group of atoms which when arranged in a linear fashion forms a flexible chain which extends up to the length of 20 amino acids likewise arranged in a linear fashion, the chemical structure being selected from the group consisting of: i) immunologically neutral chemical structures, ii) a MHC Class I epitope or a portion thereof, and/or iii) an antibody-recognized determinant or a portion thereof. Finally, the enhancing antigen presentation enhancing hybrid polypeptide includes a C-terminal element comprising an antigenic epitope in the form of a polypeptide or peptidomimetic structure which binds to the antigenic peptide binding site of an MHC class II molecule.
申请公布号 GB2439474(A) 申请公布日期 2007.12.27
申请号 GB20070015736 申请日期 2006.01.11
申请人 ANTIGEN EXPRESS ,INC 发明人 ROBERT HUMPHREYS;XU MINZHEN
分类号 C07K19/00;A61K39/00;A61K39/385;C07K14/47;C07K14/705;C12N15/12;C12N15/62 主分类号 C07K19/00
代理机构 代理人
主权项
地址